Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
After the introduction of trastuzumab, a monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2), the overall survival (OS) among patients with HER2-positive breast cancer has been substantially improved. However, among these patients, the incidence of brain metastases (BM)...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KeAi Communications Co., Ltd.
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b7d0348f3a6843e9a2eea76808764af7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|